Cargando…

LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway

Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in the development of pathological cardiac hypertrophy has not...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Mi, Jiang, Xiuxin, Li, Xinyun, Yang, Jianmin, Zhang, Cheng, Zhang, Wencheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933949/
https://www.ncbi.nlm.nih.gov/pubmed/33486894
http://dx.doi.org/10.1111/jcmm.16199